EUVIMEDEUVIMED entdecken
Open Access

Honokiol Suppresses Stemness and Sensitizes Triple-Negative Breast Cancer to Chemotherapy via YAP/TAZ-TEAD Inhibition

Jiang-Nan Xia, Shan-Dong Zhu, Wei-Ling Qu, Yi-Lin Hu, Wen-Yi Ma, Wenyan Wang, Qian-Lan Huang, Bing-Yuan Lin, Jia-En Guo, Ying-Wei Li

Oncology Research · 2026

DOI: 10.32604/or.2026.084576 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Jiang-Nan Xia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Lignans, Biphenyl Compounds, Triple Negative Breast Neoplasms, Neoplastic Stem Cells. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LignansBiphenyl CompoundsTriple Negative Breast NeoplasmsNeoplastic Stem CellsTranscription FactorsAdaptor Proteins, Signal TransducingAllyl CompoundsHumansFemalePhenolsAnimalsMiceCell Line, TumorYAP-Signaling ProteinsXenograft Model Antitumor AssaysPaclitaxelCell ProliferationTrans-ActivatorsDrug Resistance, NeoplasmAntineoplastic Agents, PhytogenicTranscriptional Coactivator with PDZ-Binding Motif ProteinsMolecular Docking SimulationGene Expression Regulation, NeoplasticTEA Domain Transcription FactorsNuclear ProteinsMice, Nude

Stichwörter der Autor:innen

HonokiolYAP/TAZ–TEAD complexcancer stem cellschemoresistancetriple-negative breast cancer

Substanzen

honokiolLignansAllyl CompoundsBiphenyl CompoundsPhenolsTranscription FactorsYAP-Signaling ProteinsPaclitaxelTrans-ActivatorsYAP1 protein, human

Autor:innen und Institutionen

  • Research Center of Integrative Medicine, School of Basic Medical Sciences, Guangzhou University of Chinese Medicine, Guangzhou, China.

Zitieren

APA

Xia, J. N., Zhu, S. D., Qu, W. L., Hu, Y. L., Ma, W. Y., Wang, W., Huang, Q. L., Lin, B. Y., Guo, J. E., & Li, Y. W. (2026). Honokiol Suppresses Stemness and Sensitizes Triple-Negative Breast Cancer to Chemotherapy via YAP/TAZ-TEAD Inhibition. Oncology Research. https://doi.org/10.32604/or.2026.084576

Vancouver

Xia JN, Zhu SD, Qu WL, Hu YL, Ma WY, Wang W, et al. Honokiol Suppresses Stemness and Sensitizes Triple-Negative Breast Cancer to Chemotherapy via YAP/TAZ-TEAD Inhibition. Oncology Research. 2026. doi:10.32604/or.2026.084576

BibTeX
@article{Xia2026,
  author = {Xia, Jiang-Nan and Zhu, Shan-Dong and Qu, Wei-Ling and Hu, Yi-Lin and Ma, Wen-Yi and Wang, Wenyan and Huang, Qian-Lan and Lin, Bing-Yuan and Guo, Jia-En and Li, Ying-Wei},
  title = {Honokiol Suppresses Stemness and Sensitizes Triple-Negative Breast Cancer to Chemotherapy via YAP/TAZ-TEAD Inhibition},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2026.084576}
}
Kostenlos starten →